Coherus BioSciences Inc (NAS:CHRS)
$ 0.73 0.06 (8.96%) Market Cap: 84.11 Mil Enterprise Value: 187.54 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 39/100

Q4 2023 Coherus BioSciences Inc Earnings Call Transcript

Mar 13, 2024 / 09:00PM GMT
Release Date Price: $2.3 (+2.68%)
Operator

Good day, and thank you for standing by, and welcome to the Q4 2023 Coherus BioSciences Inc. Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. (Operator Instructions) Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Jamie Taylor, Head of Investor Relations for Coherus.

Jami Taylor
Coherus BioSciences, Inc. - VP of IR

Thank you, operator. Good afternoon, and welcome to Coherus Biosciences Fourth Quarter and Full Year 2023 earnings conference call. Joining me today to discuss our results are Dennis Lanfear, Chief Executive Officer of Coherus; Brian McMichael, Interim Chief Financial Officer; Paul Reider, Chief Commercial Officer; Rosh Dias, Chief Medical Officer; and Theresa LaVallee, Chief Development Officer. Before we get started, I would like to remind you that today's call includes forward-looking statements regarding Coherus' current expectations about future events.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot